Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | ALKS |
---|---|---|
09:32 ET | 16428 | 24.55 |
09:34 ET | 800 | 24.58 |
09:36 ET | 1900 | 24.525 |
09:38 ET | 1000 | 24.54 |
09:39 ET | 3416 | 24.51 |
09:41 ET | 1000 | 24.53 |
09:43 ET | 2650 | 24.57 |
09:45 ET | 1804 | 24.56 |
09:48 ET | 2000 | 24.52 |
09:50 ET | 777 | 24.55 |
09:52 ET | 1950 | 24.54 |
09:54 ET | 2880 | 24.48 |
09:56 ET | 1600 | 24.415 |
09:57 ET | 2101 | 24.37 |
09:59 ET | 2410 | 24.31 |
10:01 ET | 2343 | 24.41 |
10:03 ET | 8662 | 24.39 |
10:06 ET | 1300 | 24.38 |
10:08 ET | 3777 | 24.39 |
10:10 ET | 2271 | 24.39 |
10:12 ET | 1100 | 24.445 |
10:14 ET | 12093 | 24.445 |
10:15 ET | 3390 | 24.42 |
10:17 ET | 500 | 24.45 |
10:19 ET | 53239 | 24.56 |
10:21 ET | 1760 | 24.545 |
10:24 ET | 3263 | 24.52 |
10:26 ET | 1200 | 24.47 |
10:28 ET | 1800 | 24.46 |
10:30 ET | 7800 | 24.37 |
10:32 ET | 3500 | 24.33 |
10:33 ET | 2313 | 24.345 |
10:35 ET | 3407 | 24.38 |
10:37 ET | 300 | 24.37 |
10:39 ET | 1876 | 24.34 |
10:42 ET | 3075 | 24.33 |
10:44 ET | 800 | 24.32 |
10:46 ET | 1764 | 24.28 |
10:48 ET | 1827 | 24.29 |
10:50 ET | 2554 | 24.3 |
10:51 ET | 3225 | 24.3 |
10:53 ET | 2241 | 24.24 |
10:55 ET | 2600 | 24.215 |
10:57 ET | 3416 | 24.28 |
11:00 ET | 1963 | 24.27 |
11:02 ET | 25519 | 24.34 |
11:04 ET | 2400 | 24.3 |
11:06 ET | 2665 | 24.32 |
11:08 ET | 1192 | 24.28 |
11:09 ET | 6025 | 24.3 |
11:11 ET | 2362 | 24.345 |
11:13 ET | 2700 | 24.31 |
11:15 ET | 1658 | 24.28 |
11:18 ET | 900 | 24.27 |
11:20 ET | 2058 | 24.285 |
11:22 ET | 3879 | 24.29 |
11:24 ET | 1450 | 24.25 |
11:26 ET | 1300 | 24.25 |
11:27 ET | 5240 | 24.22 |
11:29 ET | 700 | 24.21 |
11:31 ET | 800 | 24.21 |
11:33 ET | 5491 | 24.175 |
11:36 ET | 2100 | 24.18 |
11:38 ET | 1890 | 24.18 |
11:40 ET | 2142 | 24.14 |
11:42 ET | 3144 | 24.13 |
11:44 ET | 3057 | 24.14 |
11:45 ET | 1052 | 24.145 |
11:47 ET | 3500 | 24.145 |
11:49 ET | 2560 | 24.13 |
11:51 ET | 3472 | 24.16 |
11:54 ET | 2019 | 24.15 |
11:56 ET | 1660 | 24.14 |
11:58 ET | 3862 | 24.09 |
12:00 ET | 3407 | 24.11 |
12:02 ET | 861 | 24.11 |
12:03 ET | 500 | 24.105 |
12:05 ET | 4147 | 24.085 |
12:07 ET | 2539 | 24.07 |
12:09 ET | 1772 | 24.09 |
12:12 ET | 811 | 24.095 |
12:14 ET | 3968 | 24.09 |
12:16 ET | 3313 | 24.08 |
12:18 ET | 2895 | 24.095 |
12:20 ET | 2490 | 24.1 |
12:21 ET | 4335 | 24.11 |
12:23 ET | 2136 | 24.07 |
12:25 ET | 1217 | 24.06 |
12:27 ET | 1200 | 24.07 |
12:30 ET | 421 | 24.085 |
12:32 ET | 30899 | 24.06 |
12:34 ET | 3175 | 24.03 |
12:36 ET | 2654 | 24.015 |
12:38 ET | 2069 | 24.02 |
12:39 ET | 544 | 24.02 |
12:41 ET | 1632 | 24.03 |
12:43 ET | 5189 | 24.01 |
12:45 ET | 8313 | 24.08 |
12:48 ET | 1018 | 24.07 |
12:50 ET | 2919 | 24.07 |
12:52 ET | 2390 | 24.07 |
12:54 ET | 2574 | 24.04 |
12:56 ET | 1010 | 24.04 |
12:57 ET | 1420 | 24.05 |
12:59 ET | 1118 | 24.055 |
01:01 ET | 2586 | 24.05 |
01:03 ET | 1900 | 24.0675 |
01:06 ET | 2792 | 24.11 |
01:08 ET | 3916 | 24.16 |
01:10 ET | 1892 | 24.165 |
01:12 ET | 4250 | 24.13 |
01:14 ET | 1045 | 24.13 |
01:15 ET | 1285 | 24.12 |
01:17 ET | 1762 | 24.145 |
01:19 ET | 3400 | 24.12 |
01:21 ET | 1150 | 24.13 |
01:24 ET | 961 | 24.125 |
01:26 ET | 2785 | 24.15 |
01:28 ET | 2825 | 24.155 |
01:30 ET | 1626 | 24.15 |
01:32 ET | 1461 | 24.16 |
01:33 ET | 4148 | 24.19 |
01:35 ET | 300 | 24.2 |
01:37 ET | 3126 | 24.17 |
01:39 ET | 2579 | 24.16 |
01:42 ET | 700 | 24.17 |
01:44 ET | 859 | 24.17 |
01:46 ET | 5181 | 24.11 |
01:48 ET | 1615 | 24.11 |
01:50 ET | 1876 | 24.08 |
01:51 ET | 1700 | 24.06 |
01:53 ET | 1376 | 24.05 |
01:55 ET | 3105 | 24.075 |
01:57 ET | 1100 | 24.085 |
02:00 ET | 2673 | 24.1 |
02:02 ET | 1200 | 24.105 |
02:04 ET | 1404 | 24.115 |
02:06 ET | 3050 | 24.115 |
02:08 ET | 14388 | 24.08 |
02:09 ET | 3591 | 24.11 |
02:11 ET | 1550 | 24.11 |
02:13 ET | 561 | 24.105 |
02:15 ET | 2550 | 24.11 |
02:18 ET | 5292 | 24.14 |
02:20 ET | 1200 | 24.13 |
02:22 ET | 200 | 24.125 |
02:24 ET | 778 | 24.135 |
02:26 ET | 3944 | 24.125 |
02:27 ET | 1566 | 24.125 |
02:29 ET | 1663 | 24.14 |
02:31 ET | 3329 | 24.12 |
02:33 ET | 1616 | 24.135 |
02:36 ET | 1990 | 24.125 |
02:38 ET | 1278 | 24.14 |
02:40 ET | 20576 | 24.18 |
02:42 ET | 2255 | 24.18 |
02:44 ET | 1824 | 24.19 |
02:45 ET | 1616 | 24.185 |
02:47 ET | 4585 | 24.18 |
02:49 ET | 800 | 24.165 |
02:51 ET | 1773 | 24.175 |
02:54 ET | 3464 | 24.185 |
02:56 ET | 436 | 24.195 |
02:58 ET | 7930 | 24.16 |
03:00 ET | 25560 | 24.2 |
03:02 ET | 1847 | 24.185 |
03:03 ET | 700 | 24.17 |
03:05 ET | 1900 | 24.185 |
03:07 ET | 1350 | 24.205 |
03:09 ET | 3704 | 24.23 |
03:12 ET | 1660 | 24.25 |
03:14 ET | 8187 | 24.24 |
03:16 ET | 1000 | 24.245 |
03:18 ET | 4617 | 24.235 |
03:20 ET | 1306 | 24.225 |
03:21 ET | 1417 | 24.215 |
03:23 ET | 2222 | 24.21 |
03:25 ET | 3661 | 24.215 |
03:27 ET | 2441 | 24.21 |
03:30 ET | 59916 | 24.21 |
03:32 ET | 900 | 24.195 |
03:34 ET | 43134 | 24.23 |
03:36 ET | 7891 | 24.2 |
03:38 ET | 32354 | 24.23 |
03:39 ET | 4886 | 24.225 |
03:41 ET | 12881 | 24.27 |
03:43 ET | 15310 | 24.245 |
03:45 ET | 4737 | 24.245 |
03:48 ET | 12608 | 24.225 |
03:50 ET | 12109 | 24.235 |
03:52 ET | 8143 | 24.235 |
03:54 ET | 12303 | 24.235 |
03:56 ET | 30235 | 24.17 |
03:57 ET | 20699 | 24.19 |
03:59 ET | 53115 | 24.18 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Alkermes Plc | 4.1B | 6.9x | --- |
Exelixis Inc | 6.5B | 34.4x | -21.77% |
PTC Therapeutics Inc | 2.7B | -4.6x | --- |
P3 Health Partners Inc | 175.4M | -0.9x | --- |
Novavax Inc | 2.0B | -4.4x | --- |
Qiagen NV | 9.1B | 27.3x | +12.66% |
Alkermes plc is a global biopharmaceutical company that seeks to develop medicines in the field of neuroscience. The Company has a portfolio of commercial products for the treatment of alcohol dependence, opioid dependence, schizophrenia and bipolar I disorder and a pipeline of clinical and preclinical candidates in development for neurological disorders. It focuses on commercial products, such as LYBALVI, ARISTADA/ARISTADA INITIO and VIVITROL, and advancing the development of pipeline programs focused on neurological disorders. LYBALVI is a once-daily, oral atypical antipsychotic drug for the treatment of adults with schizophrenia and for the treatment of adults with bipolar I disorder, as a maintenance monotherapy or for the acute treatment of manic or mixed episodes, as monotherapy or an adjunct to lithium or valproate. ARISTADA is an extended-release intramuscular injectable suspension for the treatment of schizophrenia. It has a manufacturing facility in Wilmington, Ohio.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $4.1B |
---|---|
Revenue (TTM) | $1.7B |
Shares Outstanding | 169.2M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.44 |
EPS | $3.50 |
Book Value | $7.20 |
P/E Ratio | 6.9x |
Price/Sales (TTM) | 2.4 |
Price/Cash Flow (TTM) | 6.2x |
Operating Margin | 29.25% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.